tiprankstipranks
Paradigm Medical (PDMI)
OTHER OTC:PDMI
US Market

Paradigm Medical (PDMI) Price & Analysis

5 Followers

PDMI Stock Chart & Stats

<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)

PDMI FAQ

What was Paradigm Medical’s price range in the past 12 months?
Paradigm Medical lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
    What is Paradigm Medical’s market cap?
    Paradigm Medical’s market cap is $3.25K.
      When is Paradigm Medical’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Paradigm Medical’s earnings last quarter?
      Currently, no data Available
      Is Paradigm Medical overvalued?
      According to Wall Street analysts Paradigm Medical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Paradigm Medical pay dividends?
        Paradigm Medical does not currently pay dividends.
        What is Paradigm Medical’s EPS estimate?
        Paradigm Medical’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Paradigm Medical have?
        Paradigm Medical has 3,248,785,000 shares outstanding.
          What happened to Paradigm Medical’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Paradigm Medical?
          Currently, no hedge funds are holding shares in PDMI
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Paradigm Medical

            Paradigm Medical Industries, Inc. (PDMI) is a U.S.-based enterprise dedicated to the design, production, distribution, and sale of sophisticated medical instruments. These devices are primarily engineered for the timely diagnosis of glaucoma and a variety of other ocular conditions. The company's extensive product range addresses diverse ophthalmic diagnostic requirements. This includes biometric analyzers and A-scans like the P-2000 and P-2500 (which also function as pachymeters), along with P2700 and P37-II A/B scans. Paradigm also provides specialized blood flow analyzers, crucial for identifying and managing glaucoma and other retinal vascular disorders. Its offerings further extend to the P2200 pachymeter and the LD 500 and LD700 autoperimeters. For detailed corneal assessment, they feature the PARAVUE 300, suitable for both diagnostic imaging and contact lens fitting, and the SURVEYOR 500 for in-depth analysis of the cornea and anterior segment. The PARAMAX system, another key product, evaluates the functionality of ganglion cells to help identify individuals at risk of glaucoma. Additionally, Paradigm offers the P60 and P60 ACI ultrasound biomicroscopes, and the PARACAM 1000, a non-contact endothelial microscope. Complementing its hardware, the company also supplies essential software and various accessories. Paradigm Medical Industries was established in 1989 and operates from its headquarters in Salt Lake City, Utah.
            Similar Stocks
            Company
            Price & Change
            Follow
            Milestone Scientific
            GlucoTrack
            Innovative Eyewear, Inc.
            WORK Medical Technology Group LTD
            Popular Stocks